论文信息 - Hypermorphic mutation of phospholipase C, γ2 acquired in ibrutinib-resistant CLL confers BTK independency upon B-cell receptor activation. - 字舞流文

Hypermorphic mutation of phospholipase C, γ2 acquired in ibrutinib-resistant CLL confers BTK independency upon B-cell receptor activation.

Jeffrey A Jones | J. Byrd | A. Johnson | G. Lozanski | K. Blum | L. Andritsos | J. Flynn | S. Jaglowski | Ta-Ming Liu | Xiaoli Zhang | A. Lehman | Y. Zhong | J. Woyach | K. Maddocks | J. Dubovsky | E. Strattan | Shuai Dong | A. Lozanski | Xiaoli Zhang